Using mTOR Inhibitors in the Prevention of BK Nephropathy

NCT01649609 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

BK Viremia
BK Nephropathy

Interventions

DRUG: Tacrolimus
DRUG: Mycophenolate acid
DRUG: Sirolimus

Sponsor

Columbia University

Collaborators

[object Object]
[object Object]